Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
BIOLASE (BIOLQ)
OTHER OTC:BIOLQ
Holding BIOLQ?
Track your performance easily
Earnings Data
Report Date
Mar 26, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
―Last Year’s EPS
-1.76Same Quarter Last Year
Based on 0 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 13, 2018
|% Change Since: -83.33%
|Next Earnings Date:Aug 08, 2018
Earnings Call Sentiment|Positive
The earnings call reflects a positive outlook with notable achievements in market penetration and cost reduction, despite some challenges in the economic environment and slow technology adoption. The company remains optimistic about achieving its growth and profitability targets.Company Guidance
During the BIOLASE Q1 2024 earnings call, executives provided detailed guidance and performance metrics, highlighting a strong quarter for the company. John Beaver, President and CEO, underscored the growing adoption of their laser technology, noting that 67% of U.S. Waterlase sales were to new customers, with 42% attributed to dental specialists, amidst a significant untapped market where over 90% of dentists have yet to adopt all-tissue laser technology. The company maintained a 60% global market share and saw consumable sales increase by 14% year-over-year, marking the third strongest quarter for consumable sales. Operational improvements led to a 21% reduction in adjusted EBITDA loss, and cost-saving strategies yielded a 9% decrease in operating expenses. CFO Jennifer Bright reaffirmed full-year guidance with expected revenue growth of 6% to 8%, targeting $52 million to $53 million, and projected achieving positive adjusted EBITDA for the year, driven by cost reductions, price increases, and enhanced operational efficiency.Increased Adoption of Laser Technology
67% of U.S. Waterlase sales were from new customers, with 42% from dental specialists, indicating growing market penetration.
Strong Consumable Sales Growth
Consumable sales experienced a 14% year-over-year increase, marking the third strongest quarter for consumables in company history.
Reduction in Adjusted EBITDA Loss
Adjusted EBITDA loss decreased by 21% compared to the same quarter last year, indicating improved operational efficiency.
Cost Reduction Initiatives Success
Operating expenses decreased by 9%, largely due to cost-saving measures including a 20% reduction in workforce.
Positive Growth Outlook
Reiterated full-year 2024 guidance with expected revenue growth of 6%-8% year-over-year, aiming for positive adjusted EBITDA.
---
BIOLQ Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
BIOLQ Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Aug 08, 2024 | $0.06 | $0.05 | -16.67% |
| May 13, 2024 | $0.18 | $0.15 | -16.67% |
| Mar 21, 2024 | $0.15 | $0.18 | +20.00% |
| Nov 09, 2023 | $1.43 | $1.15 | -19.58% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does BIOLASE (BIOLQ) report earnings?
BIOLASE (BIOLQ) is schdueled to report earning on Mar 26, 2025, TBA Not Confirmed.
What is BIOLASE (BIOLQ) earnings time?
BIOLASE (BIOLQ) earnings time is at Mar 26, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is BIOLQ EPS forecast?
Currently, no data Available
---